Venetoclax is a medication used in this clinical trial. It is designed to help treat certain types of blood cancers by targeting and blocking a specific protein in cancer cells. This protein helps cancer cells survive, so by blocking it, venetoclax can help kill the cancer cells and slow down the progression of the disease. The trial aims to gather more information about the long-term safety of venetoclax for patients who have already participated in previous studies involving this medication.

Chronic Lymphocytic Leukemia – Chronic Lymphocytic Leukemia is a type of cancer that affects the blood and bone marrow. It typically progresses slowly and is characterized by the accumulation of abnormal white blood cells called lymphocytes. These cells crowd out healthy blood cells, leading to symptoms such as fatigue, swollen lymph nodes, and frequent infections. Over time, the disease can cause anemia and bleeding problems due to the reduced number of red blood cells and platelets. The progression can vary greatly among individuals, with some experiencing a stable condition for years and others having a more aggressive form.

Non-Hodgkin’s Lymphoma – Non-Hodgkin’s Lymphoma is a cancer that originates in the lymphatic system, which is part of the body’s immune system. It involves the uncontrolled growth of lymphocytes, a type of white blood cell. The disease can start in different parts of the body, such as lymph nodes, spleen, or bone marrow, and can spread to other organs. Symptoms may include swollen lymph nodes, fever, night sweats, and weight loss. The progression of Non-Hodgkin’s Lymphoma can vary, with some types growing slowly and others being more aggressive.

Multiple Myeloma – Multiple Myeloma is a cancer of plasma cells, which are a type of white blood cell found in the bone marrow. It leads to the production of abnormal proteins that can cause damage to bones and kidneys. The disease often progresses with symptoms such as bone pain, fractures, fatigue, and frequent infections. As it advances, it can lead to anemia and high calcium levels in the blood. The progression can be slow or rapid, depending on the individual case.

Acute Myeloid Leukemia – Acute Myeloid Leukemia is a fast-growing cancer of the blood and bone marrow. It is characterized by the rapid accumulation of immature white blood cells, known as myeloblasts, which interfere with the production of normal blood cells. This leads to symptoms such as fatigue, fever, easy bruising, and frequent infections. The disease progresses quickly and requires prompt medical attention. It can affect people of all ages but is more common in older adults.

Acute Lymphocytic Leukemia – Acute Lymphocytic Leukemia is a type of cancer that affects the blood and bone marrow, characterized by the overproduction of immature lymphocytes. It progresses rapidly and can cause symptoms such as fatigue, fever, bleeding, and frequent infections. The disease can spread to other parts of the body, including the lymph nodes, liver, and central nervous system. It is most common in children but can also occur in adults. The rapid progression requires immediate medical intervention.